Clinical Trials Browser

Interventional × Adenoma, Islet Cell × 30 days × Clear all

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05988918 2026-05-14

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Phase 2 Active not recruiting

17 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Somatostatinoma, Carcinoma, Adenosquamous

NCT05687123 2026-05-13

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Phase 1 Recruiting

24 enrolled

Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT04924075 2026-05-11

MK-6482-015

Phase 2 Recruiting

322 enrolled 1 FDA

CNSEndocrine

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT07554560 2026-05-07

Nutrition Intervention for Pancreatic Cancer

Phase NA Recruiting

18 enrolled

Gastrointestinal

Adenoma, Islet Cell, Exocrine Pancreatic Insufficiency

Clinical Trials

Tumor HI

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

MK-6482-015

Nutrition Intervention for Pancreatic Cancer